Meda AB
157.100.30 (0.19%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close156.80
Bid157.20 x
Ask157.30 x
52wk Range
Day's Range0.00 - 0.00
Avg Vol (3m)684,389
As of 11:29 AM EDT. Market closed.
  • Reuters5 days ago

    Mylan gets EU approval for Meda purchase, subject to conditions

    EU antitrust regulators said on Wednesday they had cleared generic drugmaker Mylan's planned cash-and-stock purchase of Sweden's Meda subject to it selling certain assets. Reuters last week reported that Mylan was set to get the green light after offering concessions. The Commission said it had identified 15 markets where it had competition concerns, because of the strong position of the two companies and the lack of sufficient alternatives.

  • Bloomberg3 months ago

    Drug Stocks Plunge Was `Necessary' Bloodletting, Mylan CEO Says

    Mylan NV’s chief executive officer says that the drug industry’s pain over the last few months will eventually be her company’s gain.